期刊文献+

基质金属蛋白酶-9与自发性高血压大鼠心肌纤维化的相关性研究 被引量:1

Correlative Research of Matrix Metalloproteinases-9 and Myocardial Fibrosis of Spontaneously Hypertensive Rats
下载PDF
导出
摘要 目的:探讨基质金属蛋白酶-9(MMP-9)与自发性高血压大鼠(SHR)心肌纤维化的相关性。方法:将16只14周龄雄性SHR随机平分为ACEI组和对照组,另以8只同龄雄性SD大鼠作为正常对照组。ACEI组以卡托普利100mg/(kg.d)灌胃,SHR对照组不灌药,于灌药12周后麻醉下取出大鼠心脏。免疫组化分析MMP-9、Collagen和的表达;RT-PCR检测MMP-9mRNA表达;MASSON染色测量胶原容积分数(CVF);碱水解法测定羟脯氨酸(Hypro)含量。结果:(1)SHR对照组LVI、CVF、Hypro、MMP-9、Collagen和的表达明显高于正常对照组(P<0.01);相对于SHR对照组,ACEI组各参数则显著降低(P<0.05);(2)MMP-9与上述指标呈高度正相关(P<0.01)。结论:MMP-9与SHR心肌纤维化密切相关,ACEI能抑制MMP-9的表达。 Objective:To investigate the correlation of matrix metalloproteinases-9(MMP-9 )and myocardial fibrosis of Spontaneously Hypertensive Rats (SHRs). Methods:16 fourteen-week-old male SHRs were randomly assigned to ACEI and control group equivalently. 8 same age male SD rats were as normal control group. A daily dose of 100 mg/ (kg · d) captopril were given to ACEI group for 12 weeks by gavage. MMP-9.Collagen Ⅰ and Ⅲ were evaluated by immunohistochemistry and RT-PCR;CVF was measured by MASSON staining;The concentration of Hypro was detected by Alkaline hydrolysis method. Results:The LVI.CVF.Hypro and the expression of MMP-9.Collagen Ⅰ and Ⅲof SHR control group were significantly higher than those of normal control group (P〈0. 01). Compared with SHR control group, these indices of ACEI group decreased obviously(P〈0.05). Conclusions:MMP-9 is closely connected with myocardial fibrosis of SHR and suppressed by ACEI.
出处 《中国误诊学杂志》 CAS 2007年第21期4954-4956,共3页 Chinese Journal of Misdiagnostics
关键词 明胶酶B/代谢/药物作用 心内膜心肌纤维化症/代谢 大鼠 近交SHR 动物 随机分配 Gelatinase B/Metabolism/drug effects Endomyocardial Fibrosis/Metabolism Rats, Inbred SHR Ani-mals Random Allocation
  • 相关文献

参考文献7

  • 1Li H,Simon H,Bocan TM,et al.MMP/TIMP expression in spontaneously hypertensive heart failure rats:the effect of ACE-and MMP-inhibition[J].Cardiovasc Res,2000,46(2):298-306.
  • 2Derosa G,D'Angelo A,Ciccarelli L,et al.Matrix metalloproteinase-2,-9,and tissue inhibitor of metalloproteinase-1 in patients with hypertension[J].Endothelium,2006,13(3):227-231.
  • 3Heymans S,Schroen B,Vermeersch P,et al.Increased cardiac expression of tissue inhibitor of metalloproteinase-1 and tissue inhibitor of metalloproteinase-2 is related to cardiac fibrosis and dysfunction in the chronic pressure-overloaded human heart[J].Circulation,2005,112(8):1136-1144.
  • 4Sakata Y,Yamamoto K,Mano T,et al.Activation of matrix metalloproteinases precedes left ventricular remodeling in hypertensive heart failure rats:its inhibition as a primary effect of Angiotensin-converting enzyme inhibitor[J].Circulation,2004,109(17):2143-2149.
  • 5Saglam M,Karakaya O,Esen AM,et al.Contribution of plasma matrix metalloproteinases to development of left ventricular hypertrophy and diastolic dysfunction in hypertensive subjects[J].Tohoku J Exp Med,2006,208(2):117-122.
  • 6Reinhardt D,Sigusch HH,Hensse J,et al.Cardiac remodelling in end stage heart failure:upregulation of matrix metalloproteinase (MMP) irrespective of the underlying disease,and evidence for a direct inhibitory effect of ACE inhibitors on MMP[J].Heart,2002,88(5):525-530.
  • 7Williams RN,Parsons SL,Morris TM,et al.Inhibition of matrix metalloproteinase activity and growth of gastric adenocarcinoma cells by an angiotensin converting enzyme inhibitor in in vitro and murine models[J].Eur J Surg Oncol,2005,31(9):1042-1050.

同被引文献24

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部